Phenylephrine

BreastfeedingPediatric
  • TRADE NAMES: Dionephrine; Dura-Vent; Neo-Synephrine; Novahistine; Prefrin Liquifilm; Prolex-D; Rynatan (MedPointe); Tussi-12D (MedPointe)
  • INDICATIONS: Nasal congestion, glaucoma, hypotension
  • CLASS: Adrenergic alpha-receptor agonist, Sympathomimetic
  • HALF-LIFE: 2.5 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Epinephrine, Furazolidone, Iobenguane, MAO inhibitors, Oxprenolol, Phenelzine, Tranylcypromine

PREGNANCY CATEGORY: C

Our database has 20 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
OCULAR.
OTHER.


Page last updated 08/26/2022

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top